Key Takeaways The S&P 500 fell 0.5% on Wednesday, Jan. 29, as the Federal Reserve held interest rates steady in a move widely ...
In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...
In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna, Inc. (MRNA), headquartered in Cambridge, Massachusetts, is a leading biotechnology company committed to pioneering ...